e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Lung infections: a clinical point of view
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The evaluation of epidemiological data and etiological reasons of bronchiectasis patients
S. Borekci, D. Demir, C. Zuhur, B. Musellim (Istanbul, Turkey)
Source:
Annual Congress 2013 –Lung infections: a clinical point of view
Session:
Lung infections: a clinical point of view
Session type:
Thematic Poster Session
Number:
2207
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Borekci, D. Demir, C. Zuhur, B. Musellim (Istanbul, Turkey). The evaluation of epidemiological data and etiological reasons of bronchiectasis patients. Eur Respir J 2013; 42: Suppl. 57, 2207
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Bronchiectasis caused by pulmonary tuberculosis: The epidemiology, clinical presentations and the differences from non-tuberculosis-caused bronchiectasis
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies?
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Diagnosis and aetiological treatment of bronchiectasis in adult patients
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Are epidemiological statistics on extrapulmonary tuberculosis correct?
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016
Pulmonary aspergilloma: epidemiology and clinical features of Iranian patients
Source: Eur Respir J 2002; 20: Suppl. 38, 352s
Year: 2002
Preliminary results of the pilot pneumonia multicentric study in the GABRIEL network for etiological agents identification
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Diagnostic contribution of PICADAR score in etiological evaluation of patients with bronchiectasis of unknown etiology
Source: International Congress 2018 – Management of bronchiectasis and large airway diseases
Year: 2018
Novel asthma definition for epidemiological studies
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
Validity of COPD diagnosis in Bronchiectasis patients: data from the EMBARC registry
Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Year: 2018
The role of clinical history and investigations in the diagnosis and exclusion of tuberculosis
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Validation of an etiological diagnostic model in adults with a diagnosis of bronchiectasis.
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Stricter microbiological criteria are useful surrogate in estimating the prevalence of nontuberculous mycobacterial pulmonary disease in Croatia
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Metabolic syndrome in patients with COPD admitted for exacerbation: Preliminary data
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Eosinophilic phenotypes of overlapping respiratory diseases in an Italian general population sample
Source: International Congress 2014 – Epidemiology of asthma
Year: 2014
Bronchiectasis: epidemiology and causes
Source: Eur Respir Mon 2011; 52: 1-10
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept